IL141869A0 - Mammalian transforming growth factor beta-9 (ztgfss9) - Google Patents
Mammalian transforming growth factor beta-9 (ztgfss9)Info
- Publication number
- IL141869A0 IL141869A0 IL14186999A IL14186999A IL141869A0 IL 141869 A0 IL141869 A0 IL 141869A0 IL 14186999 A IL14186999 A IL 14186999A IL 14186999 A IL14186999 A IL 14186999A IL 141869 A0 IL141869 A0 IL 141869A0
- Authority
- IL
- Israel
- Prior art keywords
- seq
- ztgfss9
- growth factor
- transforming growth
- factor beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15481798A | 1998-09-17 | 1998-09-17 | |
PCT/US1999/021677 WO2000015798A2 (en) | 1998-09-17 | 1999-09-17 | Mammalian transforming growth factor beta - 9 (ztgfss9) |
Publications (1)
Publication Number | Publication Date |
---|---|
IL141869A0 true IL141869A0 (en) | 2002-03-10 |
Family
ID=22552920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14186999A IL141869A0 (en) | 1998-09-17 | 1999-09-17 | Mammalian transforming growth factor beta-9 (ztgfss9) |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP1897948A1 (ja) |
JP (2) | JP2002525056A (ja) |
AT (1) | ATE378408T1 (ja) |
AU (1) | AU6050499A (ja) |
CA (2) | CA2706859A1 (ja) |
DE (1) | DE69937570T2 (ja) |
DK (1) | DK1114156T3 (ja) |
ES (1) | ES2300154T3 (ja) |
IL (1) | IL141869A0 (ja) |
WO (1) | WO2000015798A2 (ja) |
ZA (1) | ZA200101819B (ja) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999060127A2 (en) | 1998-05-15 | 1999-11-25 | Genentech, Inc. | Il-17 homologous polypeptides and therapeutic uses thereof |
US6562578B1 (en) | 1999-01-11 | 2003-05-13 | Schering Corporation | IL-17-like cytokine binding compounds and antibodies |
US7771719B1 (en) | 2000-01-11 | 2010-08-10 | Genentech, Inc. | Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E |
EP1443055A3 (en) * | 1998-05-29 | 2005-06-08 | Human Genome Sciences, Inc. | Interleukins-21 and 22 |
IL143600A0 (en) * | 1999-01-11 | 2002-04-21 | Schering Corp | Interleukin-17 related mammalian cytokines, polynucleotides encoding them and their uses |
EP2290081A3 (en) * | 1999-12-23 | 2012-08-01 | Genentech, Inc. | IL-17 homologous polypeptide and therapeutic uses thereof |
US20040043397A1 (en) | 2000-01-11 | 2004-03-04 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
US7718397B2 (en) | 2000-03-21 | 2010-05-18 | Genentech, Inc. | Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof |
US20030166268A1 (en) * | 2000-05-31 | 2003-09-04 | Holloway James L. | Mammalian transforming growth factor beta-10 |
US20030096969A1 (en) | 2000-06-02 | 2003-05-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
WO2002044379A2 (en) * | 2000-11-28 | 2002-06-06 | Amgen, Inc. | Transforming growth factor-beta-related molecules and uses thereof |
EP1359938B1 (en) | 2001-01-25 | 2011-03-16 | ZymoGenetics, Inc. | Method for treating psoriasis by using an il-17d antagonist |
AU2002318513A1 (en) * | 2001-07-06 | 2003-01-21 | Nsgene A/S | Novel neurotrophic factors |
GB0417487D0 (en) | 2004-08-05 | 2004-09-08 | Novartis Ag | Organic compound |
WO2008058251A1 (en) * | 2006-11-08 | 2008-05-15 | Zymogenetics, Inc. | Variants and methods of using transforming growth factor beta-9 |
US20090317400A1 (en) | 2008-05-05 | 2009-12-24 | Krzysztof Masternak | Anti-IL 17A/IL-17F Cross-Reactive Antibodies and Methods of Use Thereof |
MX2011011729A (es) | 2009-05-05 | 2012-04-10 | Novimmune Sa | Anticuerpo anti il-17f y metodos de uso de los mismos. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5532159A (en) * | 1994-04-01 | 1996-07-02 | The Ohio State University | Monoclonal antibody to canine placental oncofetal protein for detecting cancer |
DK0839196T3 (da) * | 1995-07-19 | 2005-09-12 | Inst Genetics Llc | Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner |
ES2223127T3 (es) * | 1997-04-25 | 2005-02-16 | Zymogenetics, Inc. | Factor 7 mamario del tipo citoquina. |
US20030003545A1 (en) | 1998-05-29 | 2003-01-02 | Reinhard Ebner | Interleukins-21 and 22 |
IL143600A0 (en) | 1999-01-11 | 2002-04-21 | Schering Corp | Interleukin-17 related mammalian cytokines, polynucleotides encoding them and their uses |
-
1999
- 1999-09-17 EP EP07017934A patent/EP1897948A1/en not_active Withdrawn
- 1999-09-17 CA CA2706859A patent/CA2706859A1/en not_active Abandoned
- 1999-09-17 ES ES99969114T patent/ES2300154T3/es not_active Expired - Lifetime
- 1999-09-17 DE DE69937570T patent/DE69937570T2/de not_active Expired - Lifetime
- 1999-09-17 IL IL14186999A patent/IL141869A0/xx unknown
- 1999-09-17 DK DK99969114T patent/DK1114156T3/da active
- 1999-09-17 WO PCT/US1999/021677 patent/WO2000015798A2/en active IP Right Grant
- 1999-09-17 EP EP99969114A patent/EP1114156B1/en not_active Expired - Lifetime
- 1999-09-17 AT AT99969114T patent/ATE378408T1/de active
- 1999-09-17 JP JP2000570325A patent/JP2002525056A/ja not_active Withdrawn
- 1999-09-17 AU AU60504/99A patent/AU6050499A/en not_active Abandoned
- 1999-09-17 CA CA2343569A patent/CA2343569C/en not_active Expired - Fee Related
-
2001
- 2001-03-05 ZA ZA200101819A patent/ZA200101819B/en unknown
-
2010
- 2010-04-22 JP JP2010098890A patent/JP2010187691A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2343569C (en) | 2010-09-14 |
DE69937570D1 (de) | 2007-12-27 |
AU6050499A (en) | 2000-04-03 |
JP2010187691A (ja) | 2010-09-02 |
EP1114156A2 (en) | 2001-07-11 |
DE69937570T2 (de) | 2009-04-23 |
WO2000015798A2 (en) | 2000-03-23 |
WO2000015798A3 (en) | 2000-05-25 |
DK1114156T3 (da) | 2008-03-03 |
CA2343569A1 (en) | 2000-03-23 |
ZA200101819B (en) | 2001-09-27 |
ES2300154T3 (es) | 2008-06-01 |
CA2706859A1 (en) | 2000-03-23 |
EP1114156B1 (en) | 2007-11-14 |
EP1897948A1 (en) | 2008-03-12 |
ATE378408T1 (de) | 2007-11-15 |
JP2002525056A (ja) | 2002-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL141869A0 (en) | Mammalian transforming growth factor beta-9 (ztgfss9) | |
HK1078093A1 (en) | Antibodies against fibroblast growth factor 23 | |
IL145288A (en) | Isolated cytokine zalpha11 ligand polypeptide and uses thereof | |
IL210455A0 (en) | Novel cytokine zcytor17 ligand | |
IL136076A0 (en) | Mammalian cytokin-like polypeptide -10 | |
DK0839196T3 (da) | Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner | |
MY123740A (en) | Il-13 receptor polypeptide | |
AU2001271786A1 (en) | Interferon-like protein zcyto21 | |
CA2083826A1 (en) | Protein having cytokine type activity, recombinant dna coding for this protein, transformed cells and microorganisms | |
BG101408A (en) | Analogs of keratinocyte growth factor | |
CA2260365A1 (en) | Differentiation-suppressive polypeptide | |
EP1037999A4 (en) | POLYPEPTIDES AND NUCLEOTIDES PORPHYROMONAS GINGIVALIS | |
AU2002307510A1 (en) | Cytokine protein family | |
CA2088068A1 (en) | Protein structure of the plant toxin gelonin | |
AU6631796A (en) | The h-y antigen | |
GB9416536D0 (en) | Orphan receptor | |
PT1847607E (pt) | Anticorpos contra a proteína p51 | |
EP1295943A4 (en) | POLYPEPTIDES CAPABLE THE POWER TO STIMULATE NEUTROPHILES | |
NZ606260A (en) | Novel polypeptides involved in immune response | |
NZ528704A (en) | Novel PRO717 polypeptides and nucleic acids encoding a 12 transmembrane polypeptide | |
NZ536317A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO1999060117A3 (fr) | Polypeptide prax-1 |